* Includes only unique trials
Basic Summary - Bacterial Vaccine
Product Trial
Competing Candidates
Product Type
Biomarker/MOA
Indication
Therapeutic Area
Sponsor
Pipeline Candidates
Marketed Drug
Biological Class
Patent Expiry
Sales Data ($ MN)
Contact
Clinical Trial Result
Basic Analysis
Product Analysis
* List the top 8 Product
* Criteria based on Biological Sub-Class
Indication Analysis
*
Includes only unique trials
* Top 8 based on Biological Sub-Class &
Indication
Therapeutic Area Analysis
* List the top 8 Therapeutic Area
* Criteria based on Biological Sub-Class
Biomarker/MOA Analysis
* List the top 8 Biomarker/MOA
* Criteria based on Biological Sub-Class
Current Development Phase
* Highest Phase based on Biological Sub-class+Indication
Sponsor Analysis
*
Includes only unique trials
* Top 8 Sponsor Analysis based on
Biological Sub-Class
Probable Licensing Opportunity
*Total number based on Biological Sub-class,Indication and Phase
Country Wise Analysis
* Country Wise Analysis
Product Level Analysis
| Therapeutic Area | Product Count |
|---|---|
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
* Top 10 product count by Biological Class
Country
Trial Id
Start Date
Completion Date
Study Title
Product
Product Type
Biological Class
Industry Type
Biomarker/MOA
Indication
Therapeutic Area
Orignal Trial Phase
Current Dev Phase
Approved/Unapproved(NDA)
Trial Status
Patent Expiry
Terminated Reason
Outcome Measures
Sponsor/Collaborator
Primary Sponsor
Sponsor Type
Sponsor Classification
Licensing Opportunity
ODD/FTA/BTA
Study Design
Study Type
Synonym
| Country | Trial ID | Start Date | Completion Date | Study Title | Product | Primary Product | Synonym | Product Type | Biological Class (If any) | Industry Type | Biomarker/MOA | Indication | Therapeutic Area | Original Trial Phase | Current Development Phase | Marketing Status | Trial Status | Prediction Of Launch | Patent Expiry Date | Sales Data ($ MN) 2023 | Terminated Reason | Outcome Measures | Clinical Trial Result | Sponsor/Collaborator | Primary Sponsor | Sponsor Type | Sponsor Classification | Probable Licensing Opportunity | Expedited Program | Contact Details | Gender | Age | Population Size | Study Design | Study Type | First Posted | Results First Posted | Last Update Posted | Location |
|---|
- US Data from January 2000 to May 2025
- Europe Data from January 2023 to September 2025
- Japan Data from January 2005 to March 2025
- Canada Data from December 2003 to September 2025
- Aus/NZ Data from January 2005 to May 2025
- Korea Data from April 2010 to July 2025
- India Data from August 2007 to March 2025